Cory Kasimov's Stock Ratings

Evercore ISI Group Analyst

Cory Kasimov is an analyst at Evercore ISI Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/31/2024

Overall Average Return

22.9%

Smart Score

Overall Average Return Percentile

82nd

Number of Ratings

		Buy Now							Get Alert
05/14/2024	ACLX	Buy Now	Arcellx	$52.00	63.46%	→ $85	Initiates	→ Outperform	Get Alert
05/14/2024	BBIO	Buy Now	BridgeBio Pharma	$28.00	78.57%	→ $50	Initiates	→ Outperform	Get Alert
05/14/2024	NBIX	Buy Now	Neurocrine Biosciences	$135.41	29.24%	→ $175	Initiates	→ Outperform	Get Alert
Make more informed trades with Benzinga Pro You're only getting a peek at the whole story!
05/14/2024	MRNA	Buy Now	Moderna	$142.37	-15.71%	→ $120	Initiates	→ In-Line	Get Alert
05/14/2024	REGN	Buy Now	Regeneron Pharmaceuticals	$980.16	17.33%	→ $1150	Initiates	→ Outperform	Get Alert
05/14/2024	BMRN	Buy Now	Biomarin Pharmaceutical	$75.07	50.53%	→ $113	Initiates	→ Outperform	Get Alert
05/14/2024	BNTX	Buy Now	BioNTech	$100.60	-0.6%	→ $100	Initiates	→ In-Line	Get Alert
02/27/2024	RARE	Buy Now	Ultragenyx Pharmaceutical	$40.14	119.23%	$84 → $88	Maintains	Overweight	Get Alert
06/05/2023	KRTX	Buy Now	Karuna Therapeutics	—	—	$260 → $250	Maintains	Overweight	Get Alert
02/11/2022	RARE	Buy Now	Ultragenyx Pharmaceutical	$40.14	228.85%	→ $132	Upgrade	Neutral → Overweight	Get Alert
01/05/2022	CERE	Buy Now	Cerevel Therapeutics Hldg	$40.74	22.73%	→ $50	Initiates	→ Overweight	Get Alert
12/21/2021	BIIB	Buy Now	Biogen	$224.94	22.7%	$324 → $276	Maintains	Neutral	Get Alert